EUROSTAR consensus offers practical guidance for monitoring, investigating, and managing symptoms after oesophagectomy or gastrectomy.

AASLD’s TLM 2026 abstract release highlights MASLD, transplant, portal hypertension, ALD, liver cancer, HBV, and cholestatic disease.

GIE meta-analysis found EGGIM ≥5 highly accurate for detecting extensive gastric intestinal metaplasia using NBI or BLI endoscopy.

A multicenter RCT found real-time peripheral gaze feedback improved adenoma and polyp detection during colonoscopy without longer observation time.

A 2026 CGH meta-analysis links higher vedolizumab trough levels with remission in IBD, strongest for endoscopic remission in UC.

Danish cohort data show alcohol remains the dominant modifiable cirrhosis risk factor, with metabolic risks adding most at lower intake.

GLOBAL-BTC registry data link chronic liver disease with earlier cholangiocarcinoma diagnosis, more surgery, and better survival.

ELATIVE phase III data show sustained biochemical response, symptom signals, stable fibrosis markers, and longer-term safety with elafibranor in PBC.

TRIDENT-UC real-world data suggest higher steroid-free remission with upadacitinib after advanced-therapy failure in moderate-to-severe UC.

FDA approval of daraxonrasib introduces a RAS-targeted option for previously treated metastatic pancreatic adenocarcinoma.

New data extend the Tokyo Guidelines 2018 difficulty score to the preoperative setting - six clinical factors that flag a hard cholecystectomy before you're in the OR

Prospective FICUS cohort data suggest liver stiffness by FibroScan may help predict transplant-free survival in compensated PSC.

Daraxonrasib has moved RAS targeting in metastatic pancreatic cancer from promise to randomized phase 3 evidence. RASolute 302 showed meaningful improvements in overall survival, progression-free sur...

A JHEP Reports study examines liver transplantation in extreme ACLF-3 patients requiring ventilation, vasopressors, and dialysis, identifying factors associated with futility.

A 2026 Gastrointestinal Endoscopy commentary and supporting comparative study examine whether EUS-guided feeder-vessel targeting can reduce coil, glue, and reintervention requirements in selected gast...

New NCI-funded research links the ZC3H15-KDM3A-cholesterol axis to FOLFIRINOX resistance in pancreatic cancer, and tests rosuvastatin as a chemosensitizer.